SCHEMBL12777133

SCHEMBL12777133

Cc1ccc(-c2ccc3ccc4c(-c5ccc(C)cc5C)cc(-c5nc6cc(-c7cccc(F)c7)ccc6o5)c5ccc2c3c54)c(C)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 11/20 0.45
▸ RAB9A P51151 11/20 0.45
▸ ALDH1A1 P00352 10/20 0.45
▸ SMN1; SMN2 Q16637 9/20 0.45
▸ NPC1 O15118 9/20 0.45
▸ HPGD P15428 9/20 0.45
▸ MAPT P10636 8/20 0.45
▸ CASP3 P42574 4/20 0.41
▸ SENP7 Q9BQF6 4/20 0.41
▸ SENP6 Q9GZR1 4/20 0.41
▸ SENP8 Q96LD8 3/20 0.41
▸ POLB P06746 1/20 0.41
▸ HSD17B10 Q99714 6/20 0.40
▸ TP53 P04637 4/20 0.40
▸ NFKB1 P19838 4/20 0.40
▸ NFKB2 Q00653 4/20 0.40
▸ RELA Q04206 4/20 0.40
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ GLA P06280 2/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12777100 0.91 MAPT (0.44) KDM4ERAB9AALDH1A1SMN1; SMN2NPC1
SCHEMBL12777115 0.91 SMN1; SMN2 (0.47) KDM4ERAB9AALDH1A1SMN1; SMN2NPC1
SCHEMBL12777118 0.90 KDM4E (0.50) KDM4ERAB9AALDH1A1SMN1; SMN2NPC1
SCHEMBL12777047 0.89 KDM4E (0.43) KDM4ERAB9AALDH1A1SMN1; SMN2NPC1
SCHEMBL12777140 0.89 HPSE (0.39) KDM4ERAB9AALDH1A1SMN1; SMN2NPC1
SCHEMBL12777202 0.86 KDM4E (0.45) KDM4ERAB9AALDH1A1SMN1; SMN2NPC1
SCHEMBL12777056 0.86 KDM4E (0.54) KDM4ERAB9AALDH1A1SMN1; SMN2NPC1
SCHEMBL12777103 0.86 KDM4E (0.56) KDM4ERAB9AALDH1A1SMN1; SMN2NPC1
SCHEMBL12777174 0.85 HDAC6 (0.41) KDM4ERAB9AALDH1A1SMN1; SMN2NPC1
SCHEMBL12777117 0.85 KDM4E (0.45) KDM4ERAB9AALDH1A1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7901794-B2 Material for light-emitting element and light emitting element TORAY INDUSTRIES, INC. (JP) 2011-03-08 — — US disclosed
US-7901794-B2 Material for light-emitting element and light emitting element TORAY INDUSTRIES, INC. (JP) 2011-03-08 — — US disclosed
US-20090066245-A1 MATERIAL FOR LIGHT-EMITTING ELEMENT AND LIGHT EMITTING ELEMENT TORAY INDUSTRIES, INC. (JP) 2009-03-12 — — US disclosed
US-20090066245-A1 MATERIAL FOR LIGHT-EMITTING ELEMENT AND LIGHT EMITTING ELEMENT TORAY INDUSTRIES, INC. (JP) 2009-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090066245-A1 MATERIAL FOR LIGHT-EMITTING ELEMENT AND LIGHT EMITTING ELEMENT PYM1, CRY1, S100A10 KDM4E 1639/4885RAB9A 3169/4885ALDH1A1 2046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback